Merck Invests In China Oncology Start-up BeiGene
This article was originally published in PharmAsia News
Executive Summary
Merck & Co. affiliate MSD has invested an undisclosed amount of debt and equity financing in the Beijing-based start-up biotech BeiGene, Ltd., BeiGene announced May 2